Andere talen BetterLife Pharma Inc.

Aandelen

BETR.F

CA08772P2026

Beurs gesloten - OTC Markets Andere beurzen 19:07:33 24-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,0719 ^USD	-3,44%		-0,28%	+49,79%

2023	BetterLife Pharma Inc. rapporteert resultaten voor het derde kwartaal en de negen maanden eindigend op 31 oktober 2023	CI
2023	US Patent and Trademark Office publiceert Betterlife's uitgebreide patent voor Betr-001 en andere LSD-derivaten	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

BetterLife Pharma Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	15/04
BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	11/04
BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	11/04
BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001	03/04
BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001	03/04
BetterLife Pharma Inc. announced that it has received CAD 1.168 million in funding	03/04
BetterLife’s 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton University	04/03
BetterLife’s 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton University	04/03
BetterLife Pharma Inc. announced that it expects to receive CAD 0.1 million in funding	04/03
BetterLife Pharma Inc. announced that it has received CAD 0.065 million in funding	04/03
BetterLife Closes Convertible Debentures For Further Development of BETR-001	02/01
BetterLife Announces Closing of Convertible Debentures For Further Development of BETR-001	02/01
BetterLife Pharma Inc. announced that it has received CAD 0.3 million in funding	02/01
BetterLife Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023	29/12
BetterLife Pharma : MANAGEMENT'S DISCUSSION AND ANALYSIS - Form 6-K	29/12
BetterLife Announces Closing of a Private Placement	18/12
BetterLife Announces Closing of a Private Placement	18/12
BetterLife Pharma Inc. announced that it has received CAD 0.2 million in funding	18/12
BetterLife Pharma : MATERIAL CHANGE REPORT - Form 6-K	30/11
Us Patent and Trademark Office Publishes Betterlife?S Comprehensive Patent for Betr-001 and Other Lsd Derivatives	30/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen BetterLife Pharma Inc.

Aandelen

BETR.F

CA08772P2026

Andere talen

Filters